Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

 1,165.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,545.00p
  • 52 Week Low: 130.00p
  • Currency: UK Pounds
  • Shares Issued: 5.36m
  • Volume: 0
  • Market Cap: £62.46m
  • RiskGrade: 340

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £2,187,020
Vladislav Sandler Ph.D. 103,862 £1,209,992
Peter Redmond 13,991 £162,995

Major Shareholders

Notifier** Holding Value*
Alexis Sandler 187,727 £2,187,020
David John Smith 143,594 £1,672,870
Dr Vladislav Sandler 103,862 £1,209,992
Optiva Securities Limited 70,329 £819,333
Flascherberg Capital Anstalt 69,991 £815,395
Craig Auringer 59,593 £694,258
HSBC Client Holdings Nominee (UK) Limited 45,160 £526,114
Ron Valk 42,828 £498,946
Samantha Bauer 42,706 £497,525
Plum Capital 29,232 £340,553
43 North LLC 28,429 £331,198
Abdelatif LACHAB 6,500 £75,725
Wayne Gibson 6,500 £75,725

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1,165.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,545.00p
52 Week Low 130.00p
Volume 0
Shares Issued 5.36m
Market Cap £62.46m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47% below the market average47% below the market average47% below the market average47% below the market average47% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Price Trend
91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average
90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page